Suppr超能文献

一名患有胰岛细胞调节异常综合征的早产儿对生长抑素类似物的耐受性

Tolerance to somatostatin analogue in a preterm infant with islet cell dysregulation syndrome.

作者信息

Hawdon J M, Ward Platt M P, Lamb W H, Aynsley-Green A

机构信息

Department of Child Health, Princess Mary Hospital, Newcastle upon Tyne.

出版信息

Arch Dis Child. 1991 Mar;66(3):341-3. doi: 10.1136/adc.66.3.341.

Abstract

An infant of 31 weeks' gestation presented with refractory neonatal hypoglycaemia secondary to islet cell dysregulation. Treatment was started with somatostatin analogue and his glycaemic control improved initially. Tolerance developed, however, in that the dose required to maintain control increased by a factor of 40. The infant subsequently underwent pancreatectomy. It is safe to use somatostatin analogue in a preterm infant, but tolerance to the drug rapidly develops.

摘要

一名孕31周的婴儿因胰岛细胞调节异常出现难治性新生儿低血糖。开始使用生长抑素类似物治疗,其血糖控制最初有所改善。然而,出现了耐受性,即维持控制所需的剂量增加了40倍。该婴儿随后接受了胰腺切除术。在早产儿中使用生长抑素类似物是安全的,但对该药物的耐受性会迅速发展。

相似文献

4
The enigma of persistent hyperinsulinemic hypoglycemia of infancy.
J Pediatr. 1993 Oct;123(4):573-5. doi: 10.1016/s0022-3476(05)80952-7.
8
Cholelithiasis in a newborn following treatment with the somatostatin analogue octreotide.
Eur J Pediatr. 2000 Jul;159(7):550. doi: 10.1007/s004310051335.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验